Odonate Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Odonate Therapeutics (ODT) IPO Opens Modestly Lower
December 7, 2017 11:31 AM ESTToday's IPO for Odonate Therapeutics (NASDAQ: ODT) opened for trading at $23 after pricing 6,250,000 shares of common stock at a public offering price of $24.00 per share.
Goldman Sachs & Co. LLC and Jefferies are acting as joint book-running managers for the offering. Cowen... More
